- 2025-09-26 10:23PD-1/PD-L1-IN-36 2714327-65-6
- 2025-09-26 10:23Friluglanstat 1422203-86-8
- 2025-09-26 10:23iNOS inhibitor-10 2918773-63-2
- 2025-09-26 10:23PD-1/PD-L1-IN-34 2924403-17-6
- 2025-09-26 10:23F092 2250261-59-5
- 2025-09-26 10:23Inflexuside B 1395048-86-8
- 2025-09-26 10:23PD-1/PD-L1-IN-33 2975602-78-7
- 2025-09-26 10:23Clopirac 42779-82-8
- 2025-09-26 10:22Inflexuside A 1395048-85-7
- 2025-09-26 10:22PD-1/PD-L1-IN-32 2765535-21-3
- 2025-09-26 10:22BRP-201 2227434-74-2
- 2025-09-26 10:22Hymenoxin 56003-01-1
- 2025-09-26 10:22PD-1/PD-L1-IN-29 intermediate-2 (N-benzyloxycarbonyl-L-serine tert-butyl ester) 59859-77-7
- 2025-09-26 10:22Benzydamine 642-72-8
- 2025-09-26 10:22PD-1/PD-L1-IN-29 intermediate-1 220095-93-2
- 2025-09-26 10:22Anti-inflammatory agent 78
- 2025-09-26 10:22hnNOS-IN-3 163490-78-6
- 2025-09-26 10:22PD-1/PD-L1-IN-29 2665734-13-2
- 2025-09-26 10:22AGU654 3038861-74-1
- 2025-09-26 10:22hnNOS-IN-2 2700326-00-5
